We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Hydroxyurea Optimization through Precision Study (HOPS)

African American physician with child
AGE: 6 months - 21 years old
TYPE: Intervention Study
CONDITION: Sickle Cell Anemia
LOCATION: UH Rainbow Babies & Children’s Hospital

Learn More About This Research Study

For more information, please call study coordinator, Mandy Rivera, at 216-844-4908 or by completing the form below.

Study Purpose

The purpose of this study is to compare the standard dosing of hydroxyurea to a new individualized way of dosing to determine whether the new dosing strategy can result in better results. Hydroxyurea is normally dosed based only on your weight. This study will select a starting dose based on how each patient absorbs hydroxyurea.

Who Can Participate

Patients 6 months of age to 21 years of age diagnosed with sickle cell anemia (HbSS, HbSD, HbS/B-thalassemia, or similarly severe SCA) may be eligible for to participate in this study.

Request More Information

Please complete the form below to learn more about this study for your child.

I'm not a robot

  • STUDYID20190803